Literature DB >> 18300795

Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia.

Do Youn Park1, Amitabh Srivastava, Gwang Ha Kim, Mari Mino-Kenudson, Vikram Deshpande, Lawrence R Zukerberg, Geum Am Song, Gregory Y Lauwers.   

Abstract

Gastric epithelial dysplasia (GED) can be morphologically categorized into adenomatous (or intestinal) and foveolar (or gastric) types. Although limited genetic differences have been demonstrated between these subtypes, the expression of various mucins has not been systematically evaluated in this context. Endoscopic mucosal resections from 69 cases of GEDs were evaluated for the expression of MUC2, MUC5AC, MUC6, and CD10. The results were correlated with morphologic categorization and clinicopathologic parameters. GED was classified as adenomatous, foveolar, or hybrid (showing features of both types), on the basis of histologic evaluation. The neighboring intestinal metaplasia (IM) was also evaluated. An adenomatous morphology was seen in 45%, hybrid type in 33.3%, and a "pure" foveolar type was seen in 21.7% of the cases. Foveolar GED was often depressed/flat on endoscopy and showed a statistically significant association with high-grade morphology (P = 0.046). Immunohistochemistry confirmed the histologic stratification. The foveolar and hybrid types were more often positive for MUC5AC (P = 0.0001 for both) and negative for CD10 (P = 0.019 and 0.016, respectively) as compared with adenomatous GED. High-grade morphology was associated with MUC5AC expression regardless of the morphologic phenotype (P = 0.026). Foveolar (73.3%) and hybrid (86.9%) GEDs were associated more often with IM showing a retained expression of gastric type mucin than adenomatous GED (29%) (P < 0.01 for both). In contrast, adenomatous type (58.1%) of GED was significantly associated with IM showing a complete intestinal phenotype (CD10+) compared with the foveolar (13.3%) and hybrid types (17.4%) of GED (P = 0.005 for both comparisons). In conclusion, our study indicates that foveolar and adenomatous types of GED have distinct clinicopathologic features, mucin profiles, and association with different types of IM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18300795     DOI: 10.1097/PAS.0b013e31815b890e

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  24 in total

1.  Nonadenomatous dysplasia in barrett esophagus: a clinical, pathologic, and DNA content flow cytometric study.

Authors:  Rachel L Rucker-Schmidt; Carissa A Sanchez; Patricia L Blount; Kumran Ayub; Xiahong Li; Peter S Rabinovitch; Brian J Reid; Robert D Odze
Journal:  Am J Surg Pathol       Date:  2009-06       Impact factor: 6.394

2.  Upper GI tract lesions in familial adenomatous polyposis (FAP): enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms.

Authors:  Laura D Wood; Safia N Salaria; Michael W Cruise; Francis M Giardiello; Elizabeth A Montgomery
Journal:  Am J Surg Pathol       Date:  2014-03       Impact factor: 6.394

3.  Epithelial dysplasia of the stomach with gastric immunophenotype shows features of biological aggressiveness.

Authors:  Pedro Valente; Mónica Garrido; Irene Gullo; Helena Baldaia; Margarida Marques; Francisco Baldaque-Silva; Joanne Lopes; Fátima Carneiro
Journal:  Gastric Cancer       Date:  2014-08-22       Impact factor: 7.370

4.  Magnifying endoscopy of gastric epithelial dysplasia based on the morphologic characteristics.

Authors:  Hwa Mi Kang; Gwang Ha Kim; Do Youn Park; Hong Ryeol Cheong; Dong Hoon Baek; Bong Eun Lee; Geun Am Song
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

5.  Mucin phenotype and narrow-band imaging with magnifying endoscopy for differentiated-type mucosal gastric cancer.

Authors:  Masaaki Kobayashi; Manabu Takeuchi; Yoichi Ajioka; Satoru Hashimoto; Akito Sato; Rintaro Narisawa; Yutaka Aoyagi
Journal:  J Gastroenterol       Date:  2011-06-11       Impact factor: 7.527

6.  The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma.

Authors:  Jochen K M Lennerz; Seok-Hyung Kim; Edward L Oates; Won Jae Huh; Jason M Doherty; Xiaolin Tian; Andrew J Bredemeyer; James R Goldenring; Gregory Y Lauwers; Young-Kee Shin; Jason C Mills
Journal:  Am J Pathol       Date:  2010-08-13       Impact factor: 4.307

Review 7.  Gastric epithelial stem cells.

Authors:  Jason C Mills; Ramesh A Shivdasani
Journal:  Gastroenterology       Date:  2010-12-07       Impact factor: 22.682

Review 8.  [Precursors of gastric cancer : Dysplasia and adenoma].

Authors:  C Langner
Journal:  Pathologe       Date:  2017-03       Impact factor: 1.011

9.  Gastric carcinogenesis.

Authors:  Ismail Gomceli; Baris Demiriz; Mesut Tez
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

10.  Colorectal cancer in Crohn's colitis is comparable to sporadic colorectal cancer.

Authors:  Jochen K Lennerz; Kimberley W J van der Sloot; Long Phi Le; Julie M Batten; Jae Young Han; Kenneth C Fan; Corey A Siegel; Amitabh Srivastava; Do Youn Park; Jey-Hsin Chen; Bruce E Sands; Joshua R Korzenik; Robert D Odze; Dora Dias-Santagata; Darrell R Borger; Hamed Khalili; A John Iafrate; Gregory Y Lauwers
Journal:  Int J Colorectal Dis       Date:  2016-03-30       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.